157 related articles for article (PubMed ID: 23866586)
21. Antibiotic resistance of lactic acid bacteria and Bifidobacterium spp. isolated from dairy and pharmaceutical products.
D'Aimmo MR; Modesto M; Biavati B
Int J Food Microbiol; 2007 Apr; 115(1):35-42. PubMed ID: 17198739
[TBL] [Abstract][Full Text] [Related]
22. Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates.
Juárez Tomás MS; Saralegui Duhart CI; De Gregorio PR; Vera Pingitore E; Nader-Macías ME
Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):399-406. PubMed ID: 21862199
[TBL] [Abstract][Full Text] [Related]
23. Beneficial lactobacilli: effects on the vaginal tract in a murine experimental model.
De Gregorio PR; Juárez Tomás MS; Santos V; Nader-Macías ME
Antonie Van Leeuwenhoek; 2012 Nov; 102(4):569-80. PubMed ID: 22638932
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains.
Mogna L; Del Piano M; Deidda F; Nicola S; Soattini L; Debiaggi R; Sforza F; Strozzi G; Mogna G
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S29-32. PubMed ID: 22955353
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of profertility effect of probiotic Lactobacillus plantarum 2621 in a murine model.
Bhandari P; Prabha V
Indian J Med Res; 2015 Jul; 142(1):79-84. PubMed ID: 26261170
[TBL] [Abstract][Full Text] [Related]
26. [Prophylactic effect of probiotic strains Bifidobacterium animalis VKL and VKB on stress-induced lesions in the gastric mucosa of rats].
Spivak MIa; Lazarenko LM; Falalieieva TM; Virchenko OV; Neporada KS
Fiziol Zh (1994); 2013; 59(2):23-30. PubMed ID: 23821934
[TBL] [Abstract][Full Text] [Related]
27. Vaginal retention of locally administered clindamycin.
Eriksson K; Larsson PG; Nilsson M; Forsum U
APMIS; 2011 Jun; 119(6):373-6. PubMed ID: 21569095
[TBL] [Abstract][Full Text] [Related]
28. Intelligent nutrition: health-promoting mechanisms of probiotics.
Amital H; Gilburd B; Shoenfeld Y
Isr Med Assoc J; 2003 Nov; 5(11):812-3. PubMed ID: 14650108
[No Abstract] [Full Text] [Related]
29. [Physiological recovery of vaginal flora, prophylaxis and treatment of bacterial vaginosis].
Akush Ginekol (Sofiia); 2008; 47(5):47-8. PubMed ID: 19227776
[No Abstract] [Full Text] [Related]
30. Use of Lactobacillus probiotics for bacterial genitourinary infections in women: a review.
Barrons R; Tassone D
Clin Ther; 2008 Mar; 30(3):453-68. PubMed ID: 18405785
[TBL] [Abstract][Full Text] [Related]
31. Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention.
Saarela M; Maukonen J; von Wright A; Vilpponen-Salmela T; Patterson AJ; Scott KP; Hämynen H; Mättö J
Int J Antimicrob Agents; 2007 Mar; 29(3):271-80. PubMed ID: 17207972
[TBL] [Abstract][Full Text] [Related]
32. The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis.
Nyirjesy P; McIntosh MJ; Gattermeir DJ; Schumacher RJ; Steinmetz JI; Joffrion JL
Am J Obstet Gynecol; 2006 May; 194(5):1277-82. PubMed ID: 16647910
[TBL] [Abstract][Full Text] [Related]
33. Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention.
Kobyliak N; Falalyeyeva T; Virchenko O; Mykhalchyshyn G; Bodnar P; Spivak M; Yankovsky D; Beregova T; Ostapchenko L
BMC Gastroenterol; 2016 Mar; 16():34. PubMed ID: 26976285
[TBL] [Abstract][Full Text] [Related]
34. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
Larsson PG; Stray-Pedersen B; Ryttig KR; Larsen S
BMC Womens Health; 2008 Jan; 8():3. PubMed ID: 18197974
[TBL] [Abstract][Full Text] [Related]
35. The influence of probiotics on the cervical malignancy diagnostics quality.
Perisić Z; Perisić N; Golocorbin Kon S; Vesović D; Jovanović AM; Mikov M
Vojnosanit Pregl; 2011 Nov; 68(11):956-60. PubMed ID: 22191313
[TBL] [Abstract][Full Text] [Related]
36. [The use of the biotherapeutic agent Zhlemik for correcting the microflora in bacterial vaginosis].
Sarkisov SE; Krymshokalova ZS; Kafarskaia LI; Korshunov VM
Zh Mikrobiol Epidemiol Immunobiol; 2000; (1):88-90. PubMed ID: 10876907
[TBL] [Abstract][Full Text] [Related]
37. Could probiotics be an option for treating and preventing urogenital infections?
Reid G; Bruce AW
Medscape Womens Health; 2001 Oct; 6(5):9. PubMed ID: 11698931
[TBL] [Abstract][Full Text] [Related]
38. Eradication of Helicobacter pylori infection by the probiotic strains Lactobacillus johnsonii MH-68 and L. salivarius ssp. salicinius AP-32.
Hsieh PS; Tsai YC; Chen YC; Teh SF; Ou CM; King VA
Helicobacter; 2012 Dec; 17(6):466-77. PubMed ID: 23067294
[TBL] [Abstract][Full Text] [Related]
39. Targeting the vaginal microbiota with probiotics as a means to counteract infections.
Reid G; Dols J; Miller W
Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):583-7. PubMed ID: 19741517
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the Safety of Lactobacillus casei IMV B-7280 Probiotic Strain on a Mouse Model.
L M L; L P B; S G G; L O S; O M D; R V B; L M S; M Ya S
Probiotics Antimicrob Proteins; 2021 Dec; 13(6):1644-1657. PubMed ID: 33876388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
